ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Louisiana » Surgical Oncology

Top Surgical Oncology Prescribers in Louisiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PETER BOSTICK MD

Surgical Oncology

599

$15.6K

121
60 are 65+

17%
patients receiving schedule two controlled substances

61%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

9%
prescriptions for brand name drugs

$26
Average prescription price

EMERY MINNARD M.D.

Surgical Oncology

597

$39K

207
156 are 65+

39%
patients receiving schedule two controlled substances

16%
patients receiving schedule three controlled substances

3%
prescriptions for patients 65+ for potentially dangerous drugs

21%
prescriptions for brand name drugs

$65
Average prescription price

ROBERT ELLIOTT M.D.

Surgical Oncology

450

$48.3K

74
64 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

6%
prescriptions for patients 65+ for potentially dangerous drugs

28%
prescriptions for brand name drugs

$107
Average prescription price

HENRY KAUFMAN

Surgical Oncology

261

$5,328

145
104 are 65+

39%
patients receiving schedule two controlled substances

32%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

7%
prescriptions for brand name drugs

$20
Average prescription price

KEVIN MARLER MD

Surgical Oncology

123

$1,870

101
94 are 65+

0%
patients receiving schedule two controlled substances

87%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

0%
prescriptions for brand name drugs

$15
Average prescription price

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank